• Home
  • >
  • Dr Lal Pathlabs Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/dr-lal-pathlabs-ltd.png Logo

Dr Lal Pathlabs Ltd Financial Statement

Dr Lal Pathlabs Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue494.9491.1545.8
Operating Expense348.7345.9368.7
Net Profit89.588.3113
Net Profit Margin18.0817.9820.7
Earning Per Share10.7310.7813.6
EBIDTA145.2145.9179
Effective Tax Rate20.5221.9722.47

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Dr Lal Pathlabs Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual2,016.882,087.411,581.27
Operating Expenses Annual1,527.051,526.681,144.99
Operating Profit Annual531.55613.27487.61
Interest Annual37.5330.1816
Depreciation47.8941.3336.58
Net Profit Annual238.85344.83291.62
Tax Annual102.75124.6997.93

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Dr Lal Pathlabs Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning378.2244.3196.72
Cash Flow from Operations456.03446.69398.15
Cash Flow from Investing-287.31-449.25-212.02
Cash Flow from Financing-283.18136.45-138.56
Cash Flow at the End263.73378.2244.3

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Dr Lal Pathlabs Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)26.3629.3830.84
PBIT Margin (%)18.9124.225.95
PBT Margin (%)18.3423.3124.23
Net PROFIT Margin (%)16.5318.3818.79
Return On Networth / Equity (%)15.2225.5126.03
Return On Networth /Employed(%)18.5129.4632.56
Return On Assets (%)15.8721.8723.11
Total Debt / Equity(X)0.210.160.02
Asset Turnover Ratio (%)0.961.191.23

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Dr Lal Pathlabs Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual1,307.031,369.37450.74
Total Current Assets Annual973.09875.151,145.17
Non Current Assets Annual1,412.481,471.6516.16
Total Shareholders Funds Annual1,666.31,501.611,245.06
Total Assets Annual2,385.562,346.751,661.33

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Dr Lal Pathlabs Ltd Earning Calls
Mar 2024
EPS beaten by 0.10 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 19, 2024, Dr Lal Pathlabs Ltd has a market capitalization of 18,888.12 Cr. Value Research classifies it as a Large-Cap company.

Yes, Dr Lal Pathlabs Ltd is debt-free with a debt-to-equity ratio of 0.13.

In FY 2023, Dr Lal Pathlabs Ltd recorded a total revenue of approximately 2,226.6 Cr marking a significant milestone in the company's financial performance.

Dr Lal Pathlabs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.0% annually, respectively..

Dr Lal Pathlabs Ltd's current PE ratio is 52.80.

Dr Lal Pathlabs Ltd's ROCE averaged 22.9% from the FY ending March 2022 to 2024, with a median of 24.8%. It peaked at 25.5% in March 2024, reflecting strong capital efficiency over the period..

Dr Lal Pathlabs Ltd's latest EBIT is Rs. 534.9 Cr, surpassing the average EBIT of Rs. 473.8 Cr over the 5 years..